GLENMARK — Glenmark Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹628.43bn
- IN₹620.37bn
- IN₹169.83bn
India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe
Brief: Glenmark Pharma Sept-Quarter Consol Net Profit At 6.1 Billion Rupees
Brief: Glenmark Pharma Settles With United Healthcare For $11 Million
Mankind Pharma posts fourth straight quarterly profit fall on sales hit from tax cuts
India's Glenmark Pharma gains on cancer drug deal with China's Jiangsu Hengrui
China's Jiangsu Hengrui to grant license for cancer drug to Swiss unit of India's Glenmark
Brief: Jiangsu Hengrui Pharmaceuticals Signs Licensing Agreement With Glenmark Specialty S.A.
Brief: Glenmark Pharma Says Unit Gets Payment For Exclusive Global Licensing Agreement For ISB 2001
India's Glenmark Pharma gains as AbbVie pays $700 mln for cancer drug rights
Brief: Glenmark Pharma Says Unit Ichnos Glenmark Innovation Received Upfront Payment Of $700 Million From AbbVie
Brief: Glenmark Pharma Initiates Multi-Country Phase 3 Clinical Trial For Envafolimab
India's Glenmark Pharma gains after starting phase three cancer drug trial
India's Glenmark Pharma rises as HSBC retains bullish view
To Launch Eribulin Mesylate Injection In Usa
Brief: Glenmark Pharma Says Glenmark Pharmaceuticals Inc To Launch Micafungin For Injection USP
India's Glenmark Pharma falls after quarterly profit drop
India's Glenmark Pharma posts lower profit on North America, Europe pricing woes
Brief: Glenmark Pharma Sees Europe, Emerging Markets Region Delivering Double-Digit Growth From Q2
Brief: Glenmark Pharmaceuticals Approves Transfer Of Consumer Care Business To Unit